QC
ABMD

Quent Capital’s Abiomed Inc ABMD Stock Holding History

Quent Capital’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5
Closed -$1K – 1378
2022
Q3 		$1K Hold
5
– – ﹤0.01% 1211
2022
Q2 		$1K Sell
5
-6
-55% -$1.62K ﹤0.01% 1157
2022
Q1 		$4K Buy
+11
New +$3.39K ﹤0.01% 1091

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Quent Capital's ABMD Position: Q4 2022 in Review

Quent Capital sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 5 shares — an estimated $1K sold.

Quent Capital first reported a position in ABMD in Q1 2022 and held it in 3 quarters. The position peaked at $4K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Quent Capital reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Quent Capital sold 5 Abiomed Inc shares in Q4 2022, an estimated $1K.
  • Quent Capital first reported a position in Abiomed Inc in Q1 2022 and held it in 3 quarters.
  • Quent Capital's Abiomed Inc position peaked at $4K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Quent Capital's 13F filing for Q4 2022, filed 19 Jan 2023.